CNA Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

CNA Financial’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,356	Closed	-$397K	–	82
2022 Q4	$397K	Sell	6,356 -4,842	-43%	-$321K	0.24%	46
2022 Q3	$789K	Sell	11,198 -1,844	-14%	-$127K	0.3%	59
2022 Q2	$739K	Hold	13,042	–	–	0.26%	79
2022 Q1	$816K	Hold	13,042	–	–	0.25%	106
2021 Q4	$730K	Hold	13,042	–	–	0.19%	134
2021 Q3	$849K	Hold	13,042	–	–	0.23%	126
2021 Q2	$827K	Hold	13,042	–	–	0.23%	129
2021 Q1	$781K	Hold	13,042	–	–	0.24%	129
2020 Q4	$651K	Buy	13,042 +1,097	+9%	+$51.5K	0.2%	137
2020 Q3	$610K	Hold	11,945	–	–	0.22%	117
2020 Q2	$419K	Buy	+11,945	New	+$411K	0.17%	141

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

CNA Financial's AXNX Position: Q1 2023 in Review

CNA Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2023, closing a stake of 6,356 shares — an estimated $397K sold.

CNA Financial first reported a position in AXNX in Q2 2020 and held it in 11 quarters. The position peaked at $849K in Q3 2021. 236 funds tracked by Wall St. Rank hold AXNX as of Q1 2023.

CNA Financial reported no remaining Axonics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
CNA Financial sold 6,356 Axonics, Inc. Common Stock shares in Q1 2023, an estimated $397K.
CNA Financial first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
CNA Financial's Axonics, Inc. Common Stock position peaked at $849K in Q3 2021.
236 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2023.

Based on CNA Financial's 13F filing for Q1 2023, filed 11 May 2023.